Kobo Biotech

Market Cap: Micro Cap
Industry: Commodity Chemicals
ISIN: INE881A01015
NSEID:
BSEID: 531541
View on BSE

INR

2.36

-0.12 (-4.84%)

BSENSE

Mar 20

BSE+NSE Vol: 2.35 k

{
  "main_header": {
    "sid": 487832,
    "name": "Kobo Biotech",
    "stock_name": "Kobo Biotech",
    "full_name": "Kobo Biotech Ltd",
    "name_url": "stocks-analysis/kobo-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.36",
    "chg": -0.12,
    "chgp": "-4.84%",
    "dir": -1,
    "prev_price": "2.48",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531541,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE881A01015",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "2.35 k",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kobo-biotech-487832-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kobo Biotech Ltd Rating Upgraded to Sell Amid Mixed Technical and Fundamental Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-rating-upgraded-to-sell-amid-mixed-technical-and-fundamental-signals-3895923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KoboBiotechLtd_mojoScore_3895923.png",
        "date": "2026-03-17 08:30:54",
        "description": "Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift driven primarily by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. The upgrade highlights a cautiously optimistic technical outlook amid persistent financial challenges and subdued market performance."
      },
      {
        "title": "Kobo Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3845216",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KoboBiotechLtd_mojoScore_3845216.png",
        "date": "2026-02-18 08:20:32",
        "description": "Kobo Biotech Ltd, a player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 17 Feb 2026. This revision reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid ongoing operational challenges and market underperformance."
      },
      {
        "title": "Kobo Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3836743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KoboBiotechLtd_mojoScore_3836743.png",
        "date": "2026-02-13 08:20:19",
        "description": "Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 12 February 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. Investors should weigh the recent mild bullish technical trends against persistent operational challenges and weak long-term financial performance."
      },
      {
        "title": "Why is Kobo Biotech Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kobo-biotech-ltd-fallingrising-3771705",
        "imagepath": "",
        "date": "2025-12-27 00:41:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend Against Market Benchmarks</strong></p>\n<p>Kobo Biotech’s recent price movement reflects a broader trend of sustained decline. Over the past week, the stock has dropped by 5.46%, sharply contrasting with the Sensex’s modest gain of 0.13% during the same period. The disparity becomes even more pronounced over longer horizons: the stock has lost more than half its value in the last year, registering a negative return of 50.66%, while the Sensex has advanced by 8.37%. Over three and five years, Kobo Biotech’s performance remains deeply disappointing, with losses exceeding 46% and 74% respectively, compared to the Sensex’s robust gains of over 40% and 81% in those periods.</p>\n<p><strong>Technical Indicators Signal Weak Momentum</strong></p>\n<p>From a technical perspective, K..."
      },
      {
        "title": "Kobo Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-is-rated-strong-sell-3771561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotechLtd_mojoScore_3771561.png",
        "date": "2025-12-26 21:51:26",
        "description": "Kobo Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 182,
    "sid": "487832",
    "stock_news_url": "https://www.marketsmojo.com/news/kobo-biotech-487832"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Feb-2026",
      "details": "Submission of certificate under Reg. 74(5) of SEBI (DP) 30.09.2024",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Feb-2026",
      "details": "Submission of certificate under Reg. 74(5) of SEBI (DP) 30.06.2024",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Feb-2026",
      "details": "Submission of Certificate under Reg. 74(5) of SEBI (DP) for 31.12.2024",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kobo Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 21 Sep 12",
          "dt": "2012-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kobo Biotech Ltd Rating Upgraded to Sell Amid Mixed Technical and Fundamental Signals

2026-03-17 08:30:54

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift driven primarily by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. The upgrade highlights a cautiously optimistic technical outlook amid persistent financial challenges and subdued market performance.

Read full news article

Kobo Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-02-18 08:20:32

Kobo Biotech Ltd, a player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 17 Feb 2026. This revision reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid ongoing operational challenges and market underperformance.

Read full news article

Kobo Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-02-13 08:20:19

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 12 February 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. Investors should weigh the recent mild bullish technical trends against persistent operational challenges and weak long-term financial performance.

Read full news article

Why is Kobo Biotech Ltd falling/rising?

2025-12-27 00:41:11

Persistent Downtrend Against Market Benchmarks

Kobo Biotech’s recent price movement reflects a broader trend of sustained decline. Over the past week, the stock has dropped by 5.46%, sharply contrasting with the Sensex’s modest gain of 0.13% during the same period. The disparity becomes even more pronounced over longer horizons: the stock has lost more than half its value in the last year, registering a negative return of 50.66%, while the Sensex has advanced by 8.37%. Over three and five years, Kobo Biotech’s performance remains deeply disappointing, with losses exceeding 46% and 74% respectively, compared to the Sensex’s robust gains of over 40% and 81% in those periods.

Technical Indicators Signal Weak Momentum

From a technical perspective, K...

Read full news article

Kobo Biotech Ltd is Rated Strong Sell

2025-12-26 21:51:26

Kobo Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.